Cargando…
CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
BACKGROUND: Cardiotrophin-like cytokine factor 1 (CLCF1) has been described as an oncogene and a potential therapeutic target in a variety of cancers, but its role in glioma remains unknown. METHODS: Based on The Cancer Genome Atlas (TCGA), we conducted a bioinformatics analysis to investigate the c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898905/ https://www.ncbi.nlm.nih.gov/pubmed/35265072 http://dx.doi.org/10.3389/fimmu.2022.810832 |
_version_ | 1784663777823686656 |
---|---|
author | Jiang, Yuan Ji, Qiankun Long, Xiaoyan Wang, Peng Tu, Zewei Zhang, Xian Zhu, Xingen Huang, Kai Li, Jingying |
author_facet | Jiang, Yuan Ji, Qiankun Long, Xiaoyan Wang, Peng Tu, Zewei Zhang, Xian Zhu, Xingen Huang, Kai Li, Jingying |
author_sort | Jiang, Yuan |
collection | PubMed |
description | BACKGROUND: Cardiotrophin-like cytokine factor 1 (CLCF1) has been described as an oncogene and a potential therapeutic target in a variety of cancers, but its role in glioma remains unknown. METHODS: Based on The Cancer Genome Atlas (TCGA), we conducted a bioinformatics analysis to investigate the clinical significance and biological functions of CLCF1 in glioma at the transcriptional level and predicted the response to immunotherapy of glioma patients with different CLCF1 expression levels. All the results were further verified in Chinese Glioma Genome Altas(CGGA) Data processing and figure generating were performed with R language. RESULTS: Elevated CLCF1 expression was common in cancers and usually predicted poor prognosis, which was also consistent with gliomas. In Univariate Cox Regression analysis and Kaplan-Meier survival analysis, tumor patients with higher CLCF1 expression tended to experience a worse prognosis. In the multivariate Cox proportional hazard model, the expression of CLCF1 was an independent prognostic factor in gliomas. The biological function analysis of CLCF1 in glioma showed that CLCF1 was closely associated with immune signatures, including immune-related pathways, immune cell infiltration, and immune checkpoints. Moreover, glioma patients with low CLCF1 expression showed a greater tendency to respond to anti-PD1/PD-L1 immunotherapy, indicating CLCF1 also had potential clinical significance in guiding immunotherapy. And CLCF1 as a member of the IL6 family had a better predictive value for prognosis and immunotherapy response in glioma than that of IL6 and other IL6 family members. CONCLUSION: CLCF1 expression is an independent prognosticator and a promising therapeutic target correlated with immunotherapy in glioma. |
format | Online Article Text |
id | pubmed-8898905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88989052022-03-08 CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma Jiang, Yuan Ji, Qiankun Long, Xiaoyan Wang, Peng Tu, Zewei Zhang, Xian Zhu, Xingen Huang, Kai Li, Jingying Front Immunol Immunology BACKGROUND: Cardiotrophin-like cytokine factor 1 (CLCF1) has been described as an oncogene and a potential therapeutic target in a variety of cancers, but its role in glioma remains unknown. METHODS: Based on The Cancer Genome Atlas (TCGA), we conducted a bioinformatics analysis to investigate the clinical significance and biological functions of CLCF1 in glioma at the transcriptional level and predicted the response to immunotherapy of glioma patients with different CLCF1 expression levels. All the results were further verified in Chinese Glioma Genome Altas(CGGA) Data processing and figure generating were performed with R language. RESULTS: Elevated CLCF1 expression was common in cancers and usually predicted poor prognosis, which was also consistent with gliomas. In Univariate Cox Regression analysis and Kaplan-Meier survival analysis, tumor patients with higher CLCF1 expression tended to experience a worse prognosis. In the multivariate Cox proportional hazard model, the expression of CLCF1 was an independent prognostic factor in gliomas. The biological function analysis of CLCF1 in glioma showed that CLCF1 was closely associated with immune signatures, including immune-related pathways, immune cell infiltration, and immune checkpoints. Moreover, glioma patients with low CLCF1 expression showed a greater tendency to respond to anti-PD1/PD-L1 immunotherapy, indicating CLCF1 also had potential clinical significance in guiding immunotherapy. And CLCF1 as a member of the IL6 family had a better predictive value for prognosis and immunotherapy response in glioma than that of IL6 and other IL6 family members. CONCLUSION: CLCF1 expression is an independent prognosticator and a promising therapeutic target correlated with immunotherapy in glioma. Frontiers Media S.A. 2022-02-21 /pmc/articles/PMC8898905/ /pubmed/35265072 http://dx.doi.org/10.3389/fimmu.2022.810832 Text en Copyright © 2022 Jiang, Ji, Long, Wang, Tu, Zhang, Zhu, Huang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Jiang, Yuan Ji, Qiankun Long, Xiaoyan Wang, Peng Tu, Zewei Zhang, Xian Zhu, Xingen Huang, Kai Li, Jingying CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma |
title | CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma |
title_full | CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma |
title_fullStr | CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma |
title_full_unstemmed | CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma |
title_short | CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma |
title_sort | clcf1 is a novel potential immune-related target with predictive value for prognosis and immunotherapy response in glioma |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898905/ https://www.ncbi.nlm.nih.gov/pubmed/35265072 http://dx.doi.org/10.3389/fimmu.2022.810832 |
work_keys_str_mv | AT jiangyuan clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT jiqiankun clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT longxiaoyan clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT wangpeng clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT tuzewei clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT zhangxian clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT zhuxingen clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT huangkai clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma AT lijingying clcf1isanovelpotentialimmunerelatedtargetwithpredictivevalueforprognosisandimmunotherapyresponseinglioma |